Read, save, and print articles from the current issue


Chronological index


Compare all instruments
and software systems


Chronological index


Register Now and
On Demand

Home » Category


Marketplace index by company

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Beckman launches hematology analyzer, software

June 2018—Beckman Coulter Diagnostics announced it received the CE mark for its DxH 520 hematology analyzer, a 5-part differential, closed-tube analyzer for small-volume laboratories.

POC hemoglobin analyzer

June 2018—EKF Diagnostics announced FDA 510(k) clearance and CLIA waiver for its Dia­Spect handheld hemoglobin analyzer.

Unyvero System gets de novo clearance

June 2018—Curetis has been granted de novo clearance by the FDA to market the Unyvero System and Lower Respiratory Tract Infection Application Cartridge in the U.S.

ConfirmMDx included in EAU guidelines

June 2018—MDxHealth announced that its ConfirmMDx is included in the 2018 European Association of Urology guidelines. Inclusion in the guidelines will facilitate adoption of the test in EU member state-specific guidelines, and the company will pursue CE marking of the test.

Sakura launches Tissue-Tek Prisma Plus

June 2018—Sakura Finetek USA launched its Tissue-Tek Prisma Plus Automated Slide Stainer, which has a throughput of 530 slides per hour.

Enzo validated antibodies for IHC

June 2018—Enzo Life Sciences introduced three clinically relevant antibodies for immunohistochemistry detection.

Nova Biomedical opens subsidiary in Switzerland

June 2018—Nova Biomedical has opened a sales and after-sales support subsidiary in the canton of Zug, outside of Zurich.

Thermo Fisher inks deal to expand Oncomine Dx

June 2018—Thermo Fisher Scientific has signed agreements with Daiichi Sankyo and Takeda Pharmaceuticals designed to expand the clinical utility of Oncomine Dx Target Test in support of clinical trials and drug development programs at the Japanese companies.

Sanquin selects Alinity s for blood, plasma screening

June 2018—Sanquin and Abbott announced they signed a multiyear contract for the supply of primary serological equipment and consumables, including Abbott’s Alinity s system, for blood and plasma screening.